BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 23630107)

  • 1. Precise comparison of protein localization among OCT, OAT, and MATE in human kidney.
    Motohashi H; Nakao Y; Masuda S; Katsura T; Kamba T; Ogawa O; Inui K
    J Pharm Sci; 2013 Sep; 102(9):3302-8. PubMed ID: 23630107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal uptake of substrates for organic anion transporters Oat1 and Oat3 and organic cation transporters Oct1 and Oct2 is altered in rats with adenine-induced chronic renal failure.
    Komazawa H; Yamaguchi H; Hidaka K; Ogura J; Kobayashi M; Iseki K
    J Pharm Sci; 2013 Mar; 102(3):1086-94. PubMed ID: 23280877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transporter studies with the 3-O-sulfate conjugate of 17alpha-ethinylestradiol: assessment of human kidney drug transporters.
    Han YH; Busler D; Hong Y; Tian Y; Chen C; Rodrigues AD
    Drug Metab Dispos; 2010 Jul; 38(7):1064-71. PubMed ID: 20360303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of organic cation transporter OCT2 and multidrug and toxin extrusion proteins MATE1 and MATE2-K for transport and drug interactions of the antiviral lamivudine.
    Müller F; König J; Hoier E; Mandery K; Fromm MF
    Biochem Pharmacol; 2013 Sep; 86(6):808-15. PubMed ID: 23876341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in the mRNA, protein, and functional expression of organic anion transporter (Oat) 1, Oat3, and organic cation transporter (Oct) 2 in rabbit renal proximal tubules.
    Groves CE; Suhre WB; Cherrington NJ; Wright SH
    J Pharmacol Exp Ther; 2006 Feb; 316(2):743-52. PubMed ID: 16249371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Nonmetabolized β-Blocker Nadolol Is a Substrate of OCT1, OCT2, MATE1, MATE2-K, and P-Glycoprotein, but Not of OATP1B1 and OATP1B3.
    Misaka S; Knop J; Singer K; Hoier E; Keiser M; Müller F; Glaeser H; König J; Fromm MF
    Mol Pharm; 2016 Feb; 13(2):512-9. PubMed ID: 26702643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirogabalin, a novel α
    Yamamura N; Mikkaichi T; Itokawa KI; Hoshi M; Damme K; Geigner S; Baumhauer C
    Xenobiotica; 2022; 52(9-11):997-1009. PubMed ID: 36170033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)].
    Xu G; Bhatnagar V; Wen G; Hamilton BA; Eraly SA; Nigam SK
    Kidney Int; 2005 Oct; 68(4):1491-9. PubMed ID: 16164626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A role for the organic anion transporter OAT3 in renal creatinine secretion in mice.
    Vallon V; Eraly SA; Rao SR; Gerasimova M; Rose M; Nagle M; Anzai N; Smith T; Sharma K; Nigam SK; Rieg T
    Am J Physiol Renal Physiol; 2012 May; 302(10):F1293-9. PubMed ID: 22338083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
    Cheng Y; Vapurcuyan A; Shahidullah M; Aleksunes LM; Pelis RM
    Drug Metab Dispos; 2012 Mar; 40(3):617-24. PubMed ID: 22190696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of clinical drug-drug interactions of veliparib (ABT-888) with human renal transporters (OAT1, OAT3, OCT2, MATE1, and MATE2K).
    Kikuchi R; Lao Y; Bow DA; Chiou WJ; Andracki ME; Carr RA; Voorman RL; De Morais SM
    J Pharm Sci; 2013 Dec; 102(12):4426-32. PubMed ID: 24122511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K).
    Saad AAA; Zhang F; Mohammed EAH; Wu X
    Biol Pharm Bull; 2022; 45(4):382-393. PubMed ID: 35370262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Organic Anion Transporter 1 or 3 in Human Kidney Proximal Tubule Cells Reduces Cisplatin Sensitivity.
    Nieskens TTG; Peters JGP; Dabaghie D; Korte D; Jansen K; Van Asbeck AH; Tavraz NN; Friedrich T; Russel FGM; Masereeuw R; Wilmer MJ
    Drug Metab Dispos; 2018 May; 46(5):592-599. PubMed ID: 29514829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal Drug Transporters and Drug Interactions.
    Ivanyuk A; Livio F; Biollaz J; Buclin T
    Clin Pharmacokinet; 2017 Aug; 56(8):825-892. PubMed ID: 28210973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
    Motohashi H; Inui K
    Mol Aspects Med; 2013; 34(2-3):661-8. PubMed ID: 23506899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of drug pharmacokinetics mediated by downregulation of kidney organic cation transporters Mate1 and Oct2 in a rat model of hyperuricemia.
    Nishizawa K; Yoda N; Morokado F; Komori H; Nakanishi T; Tamai I
    PLoS One; 2019; 14(4):e0214862. PubMed ID: 30951542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of rat renal cortical organic anion transporter (OAT1 and OAT3) expression in response to ischemia/reperfusion injury.
    Zhang R; Yang X; Li J; Wu J; Peng WX; Dong XQ; Zhou SF; Yu XQ
    Am J Nephrol; 2008; 28(5):772-83. PubMed ID: 18441523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JBP485 attenuates vancomycin-induced nephrotoxicity by regulating the expressions of organic anion transporter (Oat) 1, Oat3, organic cation transporter 2 (Oct2), multidrug resistance-associated protein 2 (Mrp2) and P-glycoprotein (P-gp) in rats.
    Wen S; Wang C; Huo X; Meng Q; Liu Z; Yang S; Zhu Y; Sun H; Ma X; Liu K
    Toxicol Lett; 2018 Oct; 295():195-204. PubMed ID: 29964132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Excretion of Dabigatran: The Potential Role of Multidrug and Toxin Extrusion (MATE) Proteins.
    Shen H; Yao M; Sinz M; Marathe P; Rodrigues AD; Zhu M
    Mol Pharm; 2019 Sep; 16(9):4065-4076. PubMed ID: 31335150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of MATE1 to Renal Secretion of the NMDA Receptor Antagonist Memantine.
    Müller F; Weitz D; Derdau V; Sandvoss M; Mertsch K; König J; Fromm MF
    Mol Pharm; 2017 Sep; 14(9):2991-2998. PubMed ID: 28708400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.